- Oral presentation
- Open Access
O026: Countrywide prevalence study of healthcare-associated infections in brazilian hospitals: preliminary results
https://doi.org/10.1186/2047-2994-2-S1-O26
© Fortaleza et al; licensee BioMed Central Ltd. 2013
Published: 20 June 2013
Keywords
- Infection Rate
- Pseudomonas Aeruginosa
- Surgical Site Infection
- Central Venous Catheter
- Bloodstream Infection
Introduction
The knowledge of burden of Healthcare-Associated Infections (HAI) in hospitals is essential to drive governmental strategies for its prevention and control.
Objectives
To identify the prevalence of HAI in a representative sample of Brazilian hospitals.
Methods
A team of trained nurses carried out a hospital-wide HAI point prevalence survey in 2012. A sample of hospitals from five Brazilian regions was evaluated (n=91; total of 8,853 beds).
Results
The overall infection rate was 11.1%, varying from 2.5% (hospitals with <50 beds) to 18.3% (hospitals with > 200 beds). Reference hospitals showed 11.2% of overall infection rate. The most prevalent infections were pneumonia (3.6%), bloodstream infection (3.5%), surgical site infection (1.4%), urinary tract infection (1.1%) and skin infection (0.4%). Hospitals with >200 beds were likely to have higher HAI rates (RR=1.71; IC=1.398-2.10; P<0.001). The risk factors more frequently identified were: central venous catheter (17.8%), surgery (15.5%), urinary catheter (14.0%), and mechanical ventilators (8.1%). Etiologic agents were identified only in 9.1% (43/473) of infections. Gram-negative organisms were more frequent (56.0%), among them, Klebsiella spp (19.0%) and Pseudomonas aeruginosa (16%) and were predominant. Among Gram-positives (35.0%), coagulase-negative Staphylococci were more prevalent (16%) than Staphylococcus aureus (9.0%) or Enteroccoccus spp (6%). Yeasts were identified in 9.0% of HAI.
Conclusion
These preliminary results emphasize both the relevance and the heterogeneity of HAI in Brazilian hospitals.
Disclosure of interest
None declared.
Authors’ Affiliations
Copyright
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
